141 related articles for article (PubMed ID: 150332)
21. Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
Piolti R; Appollonio I; Perego M; Pozzi C; Rovati L; Ferrarese C; Frattola L
Eur Neurol; 1995; 35(6):344-8. PubMed ID: 8591802
[TBL] [Abstract][Full Text] [Related]
22. gamma-Aminobutyric-acid deficiency in schizophrenia.
Koran LM
Lancet; 1976 Nov; 2(7993):1025. PubMed ID: 62243
[No Abstract] [Full Text] [Related]
23. Pallidal GABA and chorea in Huntington's disease.
Pearson SJ; Heathfield KW; Reynolds GP
J Neural Transm Gen Sect; 1990; 81(3):241-6. PubMed ID: 2144428
[TBL] [Abstract][Full Text] [Related]
24. Central cholinergic-anticholinergic antagonism in Huntington's chorea.
Klawans HL; Rubovits R
Neurology; 1972 Feb; 22(2):107-16. PubMed ID: 4257815
[No Abstract] [Full Text] [Related]
25. Huntington's chorea and bromocriptine.
Albano C; Cocito L
Arch Neurol; 1979 May; 36(5):322. PubMed ID: 156018
[No Abstract] [Full Text] [Related]
26. Effects of DA agonist in Huntington disease hyperkinesia.
Caraceni TA; Girotti F; Giovannini P; Pederzoli M; Parati EA
Ital J Neurol Sci; 1980 Jun; 1(3):155-61. PubMed ID: 6210644
[TBL] [Abstract][Full Text] [Related]
27. Isoniazid and Huntington's chorea.
Perry TL
N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007
[No Abstract] [Full Text] [Related]
28. Dimethyl aminoethanol in Huntington's chorea.
Walker JE; Hoehn M; Sears E; Lewis J
Lancet; 1973 Jun; 1(7818):1512-3. PubMed ID: 4123177
[No Abstract] [Full Text] [Related]
29. Biochemical effects in man and rat of three drugs which can increase brain GABA content.
Perry TL; Hansen S
J Neurochem; 1978 Apr; 30(4):679-84. PubMed ID: 148494
[No Abstract] [Full Text] [Related]
30. Treatment of Huntington's chorea with bromocriptine.
Frattola L; Albiazzati MG; Spano PF; Trabucchi M
Acta Neurol Scand; 1977 Jul; 56(1):37-45. PubMed ID: 141860
[TBL] [Abstract][Full Text] [Related]
31. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
Carolei A; Del Castillo G
Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
[No Abstract] [Full Text] [Related]
32. Chorea.
Klawans HL
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):536-40. PubMed ID: 2445458
[TBL] [Abstract][Full Text] [Related]
33. Neurobiology and pharmacology of Huntington's disease.
Enna SJ
Life Sci; 1977 Jan; 20(2):205-11. PubMed ID: 190505
[No Abstract] [Full Text] [Related]
34. Letter: G.A.B.A. in Huntington's chorea.
Fisher R; Norris JW; Gilka L
Lancet; 1974 Jun; 1(7870):1347-8. PubMed ID: 4134677
[No Abstract] [Full Text] [Related]
35. [Neurochemical aspects and pharmacological implications in essential tremor (preliminary note)].
Piccoli F; Smorto MP; Raimondo D; Fierro B; Vinci GG; Lupo I; Pastore L; Daniele O
Acta Neurol (Napoli); 1977; 32(4):473-80. PubMed ID: 333871
[No Abstract] [Full Text] [Related]
36. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
[No Abstract] [Full Text] [Related]
37. Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.
Stahl SM; Berger PA
Neurology; 1982 Aug; 32(8):889-92. PubMed ID: 6124899
[TBL] [Abstract][Full Text] [Related]
38. Alterations in 3H-GABA binding in Huntington's chorea.
Lloyd KG; Dreksler S; Bird ED
Life Sci; 1977 Sep; 21(5):747-53. PubMed ID: 198624
[No Abstract] [Full Text] [Related]
39. Huntington's disease: treatment with muscimol, a GABA-mimetic drug.
Shoulson I; Goldblatt D; Charlton M; Joynt RJ
Ann Neurol; 1978 Sep; 4(3):279-84. PubMed ID: 152602
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of Huntington's chorea: a pharmacological and clinical approach to the organization of the basal ganglia].
Roccatagliata G; Albano C
Clin Ter; 1980 Aug; 94(3):249-56. PubMed ID: 6450021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
